Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$6 Mln
Revenue (TTM)
$0 Mln
Net Profit (TTM)
$0 Mln
ROE
0 %
ROCE
-- %
P/E Ratio
--
P/B Ratio
0
Industry P/E
--
EV/EBITDA
0
Div. Yield
0 %
Debt to Equity
0
Book Value
$--
EPS
$--
Face value
--
Shares outstanding
33,261,500
CFO
$--
EBITDA
$--
Net Profit
$--
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Holdco Nuvo Group D.G (NUVO)
| -50.0 | 66.7 | -25.0 | -- | -- | -- | -- |
|
BSE Sensex
| 5.2 | 7.3 | 8.4 | 12.8 | 16.0 | 21.5 | 11.7 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Holdco Nuvo Group D.G (NUVO)
|
0.0 | 5.7 | 0.0 | -5.8 | -17,176.0 | -- | -- | 0.0 |
| 1.5 | 83.9 | 7.3 | 0.6 | -7.2 | 2.4 | 147 | 462.9 | |
| 60.3 | 4,459.3 | 371.5 | -4.6 | -2.1 | -1.5 | -- | 12.4 | |
| 0.3 | 30.0 | 2.1 | -0.3 | 0.0 | -- | -- | 369.0 | |
| 39.3 | 6,834.3 | 975.2 | 26.1 | 15.9 | 0.8 | 303.8 | 2.2 |
Holdco Nuvo Group D.G Ltd engages in the research, development, and marketing of medical devices for pregnancy monitoring in Israel, the United States, and internationally. It provides INVU platform, a remote pregnancy monitoring platform that... provides expectant mothers with a self -administered wireless sensory band, which enables them and their obstetricians to monitor maternal and fetal heart rate, and maternal uterine activity at home and in the clinic from the 32nd week of pregnancy until the beginning of labor. The company's INVU platform includes a wireless sensory band with multi-modality technology to capture signals to enable the INVU platform; and a cloud computing environment that processes and analyzes data and transmits personalized reports on maternal and fetal health metrics to the expectant mother and her obstetrician through digital visualization tools. It has a collaboration with Royal Philips and Charité " Universitätsmedizin Berlin. The company was formerly known as Nuvo Group Ltd. and changed its name to Holdco Nuvo Group D.G Ltd in May 2024. Holdco Nuvo Group D.G Ltd incorporated in 2006 and is headquartered in Tel Aviv, Israel. On August 22, 2024, Holdco Nuvo Group D.G Ltd filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. Read more
CEO & Director
Mr. Robert Maurice Powell Jr.
Chief Financial Officer
Mr. Douglas L. Blankenship
Headquarters
Tel Aviv
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Holdco Nuvo Group DG Ltd (NUVO) stood at $ 34 Mln as on 31-Mar-24
The share price of Holdco Nuvo Group DG Ltd (NUVO) is $0.00 (NYSE) and $0.00 (NASDAQ) as of 16-May-2025 09:30 EDT. Holdco Nuvo Group DG Ltd (NUVO) has given a return of --% in the last 1 years.
Holdco Nuvo Group DG Ltd (NUVO) has a market capitalisation of $ 6 Mln as on 16-May-2025. As per Value Research classification, it is a Small Cap company.
Since, TTM earnings of Holdco Nuvo Group DG Ltd (NUVO) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Holdco Nuvo Group DG Ltd (NUVO) and enter the required number of quantities and click on buy to purchase the shares of Holdco Nuvo Group DG Ltd (NUVO).
Holdco Nuvo Group D.G Ltd engages in the research, development, and marketing of medical devices for pregnancy monitoring in Israel, the United States, and internationally. It provides INVU platform, a remote pregnancy monitoring platform that provides expectant mothers with a self -administered wireless sensory band, which enables them and their obstetricians to monitor maternal and fetal heart rate, and maternal uterine activity at home and in the clinic from the 32nd week of pregnancy until the beginning of labor. The company's INVU platform includes a wireless sensory band with multi-modality technology to capture signals to enable the INVU platform; and a cloud computing environment that processes and analyzes data and transmits personalized reports on maternal and fetal health metrics to the expectant mother and her obstetrician through digital visualization tools. It has a collaboration with Royal Philips and Charité " Universitätsmedizin Berlin. The company was formerly known as Nuvo Group Ltd. and changed its name to Holdco Nuvo Group D.G Ltd in May 2024. Holdco Nuvo Group D.G Ltd incorporated in 2006 and is headquartered in Tel Aviv, Israel. On August 22, 2024, Holdco Nuvo Group D.G Ltd filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
The CEO & director of Mr. Robert Maurice Powell Jr.. is Holdco Nuvo Group DG Ltd (NUVO), and CFO & Sr. VP is Mr. Douglas L. Blankenship.
There is no promoter pledging in Holdco Nuvo Group DG Ltd (NUVO).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
683
|
|
|
446
|
|
|
8
|
|
|
3
|
|
|
683
|
|
|
446
|
|
|
8
|
|
|
3
|
| Holdco Nuvo Group D.G Ltd. (NUVO) | Ratios |
|---|---|
|
Return on equity(%)
|
--
|
|
Operating margin(%)
|
-17176
|
|
Net Margin(%)
|
-23128520
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Holdco Nuvo Group DG Ltd (NUVO) was $0 Mln.
